iPath Pure Beta Lead ETN
LEDD
LEDD was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $29K invested in iPath Pure Beta Lead ETN in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
4% more capital invested
Capital invested by funds: $28K → $29K (+$1K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$252 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $27K | +$252 | +6 | +0.9% |
|
|
NC
2
NewSquare Capital
Newtown Square,
Pennsylvania
| $2K | – | – | – |
|
LEDD Hedge Fund Activity: Q4 2017 in Review
2 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Lead ETN (LEDD) for Q4 2017, worth a combined $29K — up 3.6% from $28K a quarter earlier.
Fund positioning in LEDD was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $252.
- 2 institutional investors held iPath Pure Beta Lead ETN (LEDD) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $29K of iPath Pure Beta Lead ETN stock for Q4 2017, up 3.6% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Lead ETN positions in Q4 2017 and 0 closed out.
- The largest iPath Pure Beta Lead ETN buyer in Q4 2017 was UBS Group, an estimated $252 added.
Based on aggregated 13F filings for Q4 2017.